1103 Results for "

Bioavailability

" in MedChemExpress (MCE) Product Catalog:
Products (1103)

1103 Results for "Bioavailability" in MCE Product Catalog:

13
13 Cited Publications
Cat. No.: HY-10917
CAS No.: 870483-87-7
Purity:  99.90%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology Cancer

GW2580 is an orally bioavailable and selective inhibitor of c-Fms kinase which completely inhibits human cFMS kinase in vitro at 0.06 μM. GW2580 acts as a competitive inhibitor of ATP binding to the cFMS kinase and inhibits colony-stimulating-factor-1 signaling .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15968
CAS No.: 1229208-44-9
Synonyms: GS-9973
Target:  

Syk

Research Areas:  

Cancer

Entospletinib (GS-9973) is an orally bioavailable, selective Syk inhibitor with an IC50 of 7.7 nM.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15454
CAS No.: 1071992-99-8
Purity:  99.91%
Synonyms: AT-406; Debio 1143; SM-406
Target:  

IAP Apoptosis

Research Areas:  

Cancer

Xevinapant (AT-406) is a potent and orally bioavailable Smac mimetic and an antagonist of IAPs, and it binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, respectively.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15245
CAS No.: 1372540-25-4
Purity:  99.59%
Target:  

PI3K

Research Areas:  

Cancer

GSK2636771 is a potent, selective and orally bioavailable inhibitor of PI3Kβ with a Ki of 0.89 nM and an IC50 of 5.2 nM, showing 900-fold selectivity over p110α and p110γ, and 10-fold selectivity over p110δ isoforms.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15498
CAS No.: 1289023-67-1
Purity:  99.94%
Synonyms: BMS-927711; BHV-3000
Target:  

CGRP Receptor

Research Areas:  

Neurological Disease

Rimegepant (BMS-927711; BHV-3000) is an orally bioavailable and blood-brain barrier permeable antagonist of CGRP and AMY1 receptors, with a pIC50 of 8.01 and a Ki of 0.027 nM for human CGRP receptors. Rimegepant antagonizes cAMP production induced by αCGRP, βCGRP and amylin at CGRP and AMY1 receptors in humans, rats and mice, as well as at rat AMY3 receptors. Rimegepant can be used in research related to migraine .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-13208
CAS No.: 1071992-57-8
Purity:  98.01%
Synonyms: AT-406 hydrochloride; Debio 1143 hydrochloride; SM-406 hydrochloride
Target:  

IAP Apoptosis

Research Areas:  

Cancer

Xevinapant (AT-406) hydrochloride is a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs). Xevinapant hydrochloride binds to XIAP, cIAP1, and cIAP2 proteins with Kis of 66.4, 1.9, and 5.1 nM, respectively. Xevinapant hydrochloride effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degradation of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines. Xevinapant hydrochloride is highly effective in induction of apoptosis in xenograft tumors .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-18658
CAS No.: 1448867-41-1
Synonyms: NVP-HDM201; HDM201
Research Areas:  

Cancer

Siremadlin (NVP-HDM201) is a potent, orally bioavailable and highly specific p53-MDM2 interaction inhibitor.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-15891A
CAS No.: 197890-44-1
Purity:  98.71%
Synonyms: GW311616A
Target:  

Elastase

Research Areas:  

Inflammation/Immunology

GW-311616 is a potent, orally bioavailable, long duration and selective human neutrophil elastase (HNE) inhibitor with IC50 value of 22 nM and Ki value of 0.31 nM .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-124603
CAS No.: 1219962-49-8
Purity:  ≥98.0%
Research Areas:  

Inflammation/Immunology

AT791 is a potent and orally bioavailable TLR7 and TLR9 inhibitor. AT791 inhibits TLR7 and 9 signaling in a variety of human and mouse cell types and inhibits DNA-TLR9 interaction in vitro .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-12947
CAS No.: 1496581-76-0
Purity:  99.54%
Target:  

MAP3K

Research Areas:  

Neurological Disease

GNE-3511 is an orally active bioavailable and brain-penetrant dual leucine zipper kinase (DLK) inhibitor with a Ki of 0.5 nM. GNE-3511 can cross the blood-brain-barrier and can be used for the research of neurodegenerative diseases .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-12802
CAS No.: 1531634-31-7
Purity:  99.28%
Target:  

Neurotensin Receptor

Research Areas:  

Neurological Disease

AF38469 is a selective, orally bioavailable Sortilin inhibitor with an IC50 value of 330 nM.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-14178
CAS No.: 896720-20-0
Purity:  98.94%
Target:  

ERK

Research Areas:  

Cancer

VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-15976
CAS No.: 301353-96-8
Target:  

Others

Research Areas:  

Neurological Disease

P7C3 is an orally bioavailable and blood-brain barrier penetrant aminopropyl carbazole, with neuroprotective effects. P7C3 can be used for the research of neurodegenerative diseases, including Parkinson's disease .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-119339
CAS No.: 1648843-04-2
Purity:  99.67%
Target:  

CXCR

SX-682 is an orally bioavailable, potent allosteric inhibitor of CXCR1 and CXCR2. SX-682 can block tumor myeloid-derived suppressor cells (MDSCs) recruitment and enhance T cell activation and antitumor immunity .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-117650A
CAS No.: 2072057-17-9
Purity:  99.85%
Synonyms: RO 7020322; (S)-RO0321
Target:  

HBV

Research Areas:  

Infection

RG7834 (RO 7020322) is a highly selective and orally bioavailable HBV inhibitor, potently inhibits HBV antigens (both HBsAg and HBeAg) and HBV DNA, with IC50s of 2.8, 2.6, and 3.2 nM, respectively, in dHepaRG Cells .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-144858
CAS No.: 2411748-50-8
Purity:  99.11%
Research Areas:  

Cancer

EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 (IC50=18 nM in SETD2 biochemical assay; IC50=34 nM in cellular assay). EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-18204A
CAS No.: 936623-90-4
Synonyms: LCZ696
Sacubitril/Valsartan (LCZ696), comprised Valsartan and Sacubitril (AHU377) in 1:1 molar ratio, is a first-in-class, orally bioavailable, and dual-acting angiotensin receptor-neprilysin (ARN) inhibitor for hypertension and heart failure . Sacubitril/Valsartan ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-101761
CAS No.: 1190221-43-2
Purity:  99.08%
Target:  

PAI-1 Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor-1 (PAI-1), has IC50 values between 13.9 and 51.1 μM and induces intrinsic apoptosis in several human cancer cell lines. TM5441 attenuates Nω-nitro-l-arginine methyl ester-induced cardiac hypertension and vascular senescence .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-13735A
CAS No.: 69-05-6
Purity:  99.38%
Synonyms: Mepacrine dihydrochloride; SN-390 dihydrochloride
Research Areas:  

Infection Cancer

Quinacrine (Mepacrine) dihydrochloride is an orally bioavailable antimalarial agent, which possess anticancer effect both in vitro and vivo. Quinacrine dihydrochloride suppresses NF-κB and activate p53 signaling, which results in the induction of the apoptosis .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-N0269
CAS No.: 34221-41-5
Echinatin is a chalcone isolated from the Chinese herbal medicine Gancao with hepatoprotective and anti-inflammatory effects . Echinatin can be quickly absorbed and eliminated and extensively distributed with an absolute bioavailability of approximately 6.81% in Rat .
loading...
    loading...